OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 25, 2020
As coronavirus disease 2019 (COVID-19) cases rise across the country, members of the MJH Life Sciences COVID-19 Coalition shared their perspectives on pandemic containment efforts.
November 23, 2020
Infectious Disease Society of America offered a look at the current treatment options for COVID-19 and stressed the need to maintain precautions to keep people safe.
One vaccine dosing regimen for AZD1222 showed 90% efficacy, according to investigators at the University of Oxford.
November 20, 2020
Here's the roundup of this week's coronavirus-related news.
Results from the NIAID-sponsored ACTT-2 trial showed that COVID-19 patients treated with baricitinib in combination with remdesivir experienced better recovery times and clinical status.
Pfizer and BioNTech expect to produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021.
November 19, 2020
Officials with Operation Warp Speed said distribution of a COVID-19 vaccine will begin within 24 hours after FDA authorization.
November 18, 2020
Pfizer and BioNTech today announced that their COVID-19 vaccine candidate showed a 95% efficacy rate in the final analysis of its phase 3 study.
November 16, 2020
Moderna announced today that its messenger RNA vaccine candidate for COVID-19 met the primary endpoint of efficacy, according to the study’s first interim analysis.
November 13, 2020
Here’s a roundup of the latest coronavirus-related news.